ETHOSUXIMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ethosuximide, and what generic alternatives are available?
Ethosuximide is a drug marketed by Bionpharma, Epic Pharma Llc, Heritage Pharms Inc, Puracap Pharm Llc, Strides Pharma, Mikart, Pharm Assoc, and Teva Pharms. and is included in eight NDAs.
The generic ingredient in ETHOSUXIMIDE is ethosuximide. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ethosuximide
A generic version of ETHOSUXIMIDE was approved as ethosuximide by PHARM ASSOC on November 22nd, 2000.
Summary for ETHOSUXIMIDE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Clinical Trials: | 12 |
Patent Applications: | 4,062 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ETHOSUXIMIDE |
What excipients (inactive ingredients) are in ETHOSUXIMIDE? | ETHOSUXIMIDE excipients list |
DailyMed Link: | ETHOSUXIMIDE at DailyMed |
Recent Clinical Trials for ETHOSUXIMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins University | Phase 3 |
Tanta University | Phase 3 |
Zhejiang University | Early Phase 1 |
Pharmacology for ETHOSUXIMIDE
Drug Class | Anti-epileptic Agent |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |